UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T >MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

International journal of antimicrobial agents, 2008-04, Vol.31 (4), p.345-351

2008

Volltextzugriff (PDF)

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Clinical infectious diseases, 2003-06, Vol.36 (11), p.1418-1423

2003

Volltextzugriff (PDF)

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

Diagnostic microbiology and infectious disease, 2010-07, Vol.67 (3), p.228-233

2010

Volltextzugriff (PDF)

Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3731-3733

2007

Volltextzugriff (PDF)

Burden of Methicillin-Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes

Pharmacotherapy, 2007-07, Vol.27 (7), p.1001-1012

2007

Volltextzugriff (PDF)

Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus

Infection control and hospital epidemiology, 2006-10, Vol.27 (10), p.1025

2006

Volltextzugriff (PDF)

Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients

The Annals of pharmacotherapy, 2007-04, Vol.41 (4), p.568-573

2007

Volltextzugriff (PDF)

Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia

Chest, 2005-09, Vol.128 (3), p.1414-1422

2005

Volltextzugriff (PDF)

Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Pharmacotherapy, 2010-06, Vol.30 (6), p.554-561

2010

Volltextzugriff (PDF)

A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

Pharmacotherapy, 2005-10, Vol.25 (10), p.1303-1309

2005

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal Function

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1853-1861

2003

Volltextzugriff (PDF)

Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin-Resistant Enterococcus in a Level 1 Trauma Center

Clinical infectious diseases, 2002-04, Vol.34 (7), p.922-929

2002

Volltextzugriff (PDF)

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

Diagnostic microbiology and infectious disease, 2005-06, Vol.52 (2), p.113-122

2005

Volltextzugriff (PDF)

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia : Specific evaluation of vancomycin pharmacokinetic indices

Chest, 2006-10, Vol.130 (4), p.947-955

2006

Volltextzugriff (PDF)

Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S108-S111

2014

Volltextzugriff (PDF)

Pharmacodynamics of cefepime in patients with Gram-negative infections

Journal of antimicrobial chemotherapy, 2002-09, Vol.50 (3), p.425-428

2002

Volltextzugriff (PDF)

Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes

Pharmacotherapy, 2007-12, Vol.27 (12), p.1611-1618

2007

Volltextzugriff (PDF)

Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S179-S184

2014

Volltextzugriff (PDF)

Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance

Infection control and hospital epidemiology, 2003-09, Vol.24 (9), p.655-661

2003

Volltextzugriff (PDF)

Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center

Pharmacotherapy, 2008-01, Vol.28 (1), p.64-73

2008

Volltextzugriff (PDF)

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections

The Annals of pharmacotherapy, 2006-06, Vol.40 (6), p.1017

2006

Volltextzugriff (PDF)

Pharmacoeconomic Considerations Associated with the Use of Intravenous-to-Oral Moxifloxacin for Community-Acquired Pneumonia

Clinical infectious diseases, 2005-07, Vol.41 (Supplement-2), p.S136-S143

2005

Volltextzugriff (PDF)

Clinical Outcomes and Cost Minimization with an Alternative Dosing Regimen for Meropenem in a Community Hospital

Pharmacotherapy, 2007-12, Vol.27 (12), p.1637-1643

2007

Volltextzugriff (PDF)

Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem-Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever

Pharmacotherapy, 2009-08, Vol.29 (8), p.914-923

2009

Volltextzugriff (PDF)

Optimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care

Hospital Practice, 2011-04, Vol.39 (2), p.18-31

2011

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Humans
(55)
Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Biological And Medical Sciences
(34)
Medical Sciences
(34)
Middle Aged
(33)
Male
(32)
Female
(31)
Adult
(29)
Pharmacology. Drug Treatments
(25)
Aged
(24)
Pharmacology & Pharmacy
(23)
Infectious Diseases
(19)
Treatment Outcome
(18)
Anti-Bacterial Agents - Therapeutic Use
(15)
Microbiology
(15)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(14)
Retrospective Studies
(14)
Antibacterial Agents
(12)
Cohort Studies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T >MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

Impact of Empirical-Therapy Selection on Outcomes of Intravenous Drug Users with Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus

Burden of Methicillin-Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes

Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus

Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients

Epidemiology, Treatment, and Outcomes of Nosocomial Bacteremic Staphylococcus aureus Pneumonia

Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal Function

Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin-Resistant Enterococcus in a Level 1 Trauma Center

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia : Specific evaluation of vancomycin pharmacokinetic indices

Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists

Pharmacodynamics of cefepime in patients with Gram-negative infections

Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes

Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance

Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center

Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections

Pharmacoeconomic Considerations Associated with the Use of Intravenous-to-Oral Moxifloxacin for Community-Acquired Pneumonia

Clinical Outcomes and Cost Minimization with an Alternative Dosing Regimen for Meropenem in a Community Hospital

Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem-Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever

Optimizing Delivery of Care for Patients with MRSA Infection: Focus on Transitions of Care

Suchergebnisse filtern